Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Blood (2014) 124 (21): 405.

https://doi.org/10.1182/blood.V124.21.405.405

Published: 2014

Journal Articles

Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasms: A Study of the AGIMM & IWG-MRT Groups in 519 Subjects

Blood (2014) 124 (21): 3163.

https://doi.org/10.1182/blood.V124.21.3163.3163

Published: 2014

Journal Articles

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, BS, Christian A Di Buduo, PhD, Marta Bellini, MD, Ilaria Carola Casetti, MD, Chiara Cavalloni, MD, Emanuela Sant'Antonio, Vittorio Abbonante, PhD, Maria C Renna, BS, Virginia Ferretti, PhD, Emanuela Boveri, MD, Alessandra Balduini, MD, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2014) 124 (21): 3215.

https://doi.org/10.1182/blood.V124.21.3215.3215

Published: 2014

Journal Articles

A Novel Approach to a Retrospective Longitudinal Analysis of Dose Change or Discontinuation of Imatinib Therapy in Chronic Phase–Chronic Myeloid Leukemia

Serena Merante, MD, Cristiana Pascutto, PhD, Chiara Elena, MD, Barbara Rocca, BSc, Rita Zappatore, PhD, Paola Maria Cavigliano, BSc, Mario Cazzola, MD, Ester Orlandi, MD

Blood (2014) 124 (21): 4543.

https://doi.org/10.1182/blood.V124.21.4543.4543

Published: 2014

Journal Articles

High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone Lymphoma : An EBMT-FIL-Gimeto Retrospective Study

Blood (2014) 124 (21): 2526.

https://doi.org/10.1182/blood.V124.21.2526.2526

Published: 2014

Journal Articles

Post-Polycythemia and Post-Thrombocythemia Myelofibrosis Have Distinctive Clinical Phenotypes: An International Multicenter Study on 718 Patients

Blood (2014) 124 (21): 1824.

https://doi.org/10.1182/blood.V124.21.1824.1824

Published: 2014

Journal Articles

A New International Multicenter-Based Model to Predict Survival in Myelofibrosis Secondary to Polycythemia and Thrombocythemia: The Mysec Prognostic Model (MYSEC-PM)

Blood (2014) 124 (21): 1826.

https://doi.org/10.1182/blood.V124.21.1826.1826

Published: 2014

Journal Articles

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)

Matteo Giovanni Della Porta, Emilio Paolo Alessandrino, MD, Christopher H Jackson, Cristiana Pascutto, PhD, Andrea Bacigalupo, MD, Luca Malcovati, MD, Maria Teresa Van Lint, MD, Bernardino Allione, Massimo Bernardi, MD, Francesco Onida, MD, Stefano Guidi, Anna Paola Iori, MD, Raffaella Cerretti, MD, Paola Marenco, MD, Pietro Pioltelli, Emanuele Angelucci, Alberto Bosi, MD, Mario Cazzola, MD, Alessandro Rambaldi, MD

Blood (2014) 124 (21): 531.

https://doi.org/10.1182/blood.V124.21.531.531

Published: 2014

Journal Articles

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Blood (2014) 124 (9): 1513–1521.

https://doi.org/10.1182/blood-2014-03-560227

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

Blood (2014) 124 (7): 1062–1069.

https://doi.org/10.1182/blood-2014-05-578435

Published: 2014

Journal Articles

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

Blood (2014) 123 (15): 2333–2342.

https://doi.org/10.1182/blood-2013-12-542720

Published: 2014

Includes: Supplemental data

Journal Articles

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Jelena D. Milosevic, Ilaria C. Casetti, Marta Bellini, Nicole C. C. Them, Chiara Cavalloni, Virginia V. Ferretti, Chiara Milanesi, Tiina Berg, Emanuela Sant’Antonio, Emanuela Boveri, Cristiana Pascutto, Cesare Astori, Robert Kralovics, Mario Cazzola

Blood (2014) 123 (15): 2416–2419.

https://doi.org/10.1182/blood-2014-01-550434

Published: 2014

Includes: Supplemental data

Journal Articles

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts

Francesco Passamonti, Margherita Maffioli, Francisco Cervantes, Alessandro Maria Vannucchi, Enrica Morra, Tiziano Barbui, Domenica Caramazza, Lisa Pieri, Elisa Rumi, Heinz Gisslinger, Laurent Knoops, Jean Jaques Kiladjian, Barbara Mora, Norbert Hollaender, Cristiana Pascutto, Claire Harrison, Mario Cazzola

Blood (2014) 123 (12): 1833–1835.

https://doi.org/10.1182/blood-2013-12-544411

Published: 2014

Journal Articles

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Blood (2014) 123 (10): 1544–1551.

https://doi.org/10.1182/blood-2013-11-539098

Published: 2014

Includes: Supplemental data

Journal Articles

High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents

Silvia Mangiacavalli, MD, Alessandra Pompa, MD, Cristiana Pascutto, PhD, Virginia Ferretti, DR, Lara Pochintesta, MD, Federica Cocito, MD, Marzia Varettoni, Mario Lazzarino, Prof, Mario Cazzola, MD, Alessandro Corso, MD

Blood (2013) 122 (21): 1896.

https://doi.org/10.1182/blood.V122.21.1896.1896

Published: 2013

Journal Articles

The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making

Matteo G Della Porta, MD, Emilio Paolo Alessandrino, MD, Andrea Bacigalupo, MD, Bernardino Allione, MD, Luca Malcovati, MD, Maria Teresa van Lint, MD, Massimo Bernardi, MD, Francesco Onida, MD, Alberto Bosi, MD, Anna Paola Iori, MD, Raffaella Cerretti, MD, Paola Marenco, MD, Pietro Pioltelli, MD, Emanuele Angelucci, MD, Rosi Oneto, Cristiana Pascutto, PhD, Mario Cazzola, MD, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 2765.

https://doi.org/10.1182/blood.V122.21.2765.2765

Published: 2013

Journal Articles

Impact Of Ruxolitinib On The Natural History Of Patients With Primary Myelofibrosis: A Retrospective Comparison Of The DIPSS and The Comfort-2 Cohorts

Francesco Passamonti, MD, Margherita Maffioli, MD, Francisco Cervantes, MD, PhD, Alessandro M. Vannucchi, MD, PhD, Enrica Morra, MD, Tiziano Barbui, MD, Caramazza Domenica, MD, Elisa Rumi, MD, Gisslinger Heinz, Laurent Knoops, MD, PhD, Barbara Mora, MD, Norbert Hollaender, PhD, Margaret Squier, MD, PhD, Cristiana Pascutto, Claire N Harrison, DM, FRCP, FRCPath, Mario Cazzola, MD

Blood (2013) 122 (21): 4066.

https://doi.org/10.1182/blood.V122.21.4066.4066

Published: 2013

Journal Articles

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

Elisa Rumi, MD, Daniela Pietra, PhD, Chiara Elena, MD, Ilaria Casetti, MD, Emanuela Sant 'Antonio, MD, Cesare Astori, MD, Chiara Milanesi, PhD, Marta Bellini, MD, Emanuela Boveri, MD, Virginia Ferretti, DR, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1592.

https://doi.org/10.1182/blood.V122.21.1592.1592

Published: 2013

Journal Articles

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance

Marzia Varettoni, Silvia Zibellini, Luca Arcaini, Emanuela Boveri, Sara Rattotti, Cristiana Pascutto, Silvia Mangiacavalli, Manuel Gotti, Lara Pochintesta, Marco Paulli, Mario Cazzola

Blood (2013) 122 (13): 2284–2285.

https://doi.org/10.1182/blood-2013-07-513366

Published: 2013

Journal Articles

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL -mutated myeloproliferative neoplasms

Blood (2013) 121 (21): 4388–4395.

https://doi.org/10.1182/blood-2013-02-486050

Published: 2013

Includes: Supplemental data

NARROW

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasms: A Study of the AGIMM & IWG-MRT Groups in 519 Subjects

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

A Novel Approach to a Retrospective Longitudinal Analysis of Dose Change or Discontinuation of Imatinib Therapy in Chronic Phase–Chronic Myeloid Leukemia

High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone Lymphoma : An EBMT-FIL-Gimeto Retrospective Study

Post-Polycythemia and Post-Thrombocythemia Myelofibrosis Have Distinctive Clinical Phenotypes: An International Multicenter Study on 718 Patients

A New International Multicenter-Based Model to Predict Survival in Myelofibrosis Secondary to Polycythemia and Thrombocythemia: The Mysec Prognostic Model (MYSEC-PM)

Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Clinical effect of driver mutations of JAK2 , CALR , or MPL in primary myelofibrosis

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents

The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making

Impact Of Ruxolitinib On The Natural History Of Patients With Primary Myelofibrosis: A Retrospective Comparison Of The DIPSS and The Comfort-2 Cohorts

JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL -mutated myeloproliferative neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only